| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0001 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 4.6e-05 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 2e-05 | 1 |